Edge Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Edge Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$143K	Sell	1,305 -44	-3%	-$4.71K	0.01%	357
2018 Q1	$144K	Buy	1,349 +44	+3%	+$4.88K	0.01%	354
2017 Q4	$139K	Hold	1,305	–	–	0.01%	348
2017 Q3	$145K	Hold	1,305	–	–	0.02%	343
2017 Q2	$134K	Buy	1,305 +249	+24%	+$24.5K	0.02%	355
2017 Q1	$103K	Hold	1,056	–	–	0.01%	400
2016 Q4	$93K	Buy	+1,056	New	+$96.1K	0.01%	390

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Edge Advisors's IBB Position: Q2 2018 in Review

Edge Advisors reduced its iShares Biotechnology ETF (IBB) stake by 3.3% in Q2 2018, selling an estimated $4.71K and leaving 1,305 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #357.

Edge Advisors first reported a position in IBB in Q4 2016 and has held it in 7 quarters since. The position peaked at $145K in Q3 2017. 609 funds tracked by Wall St. Rank hold IBB as of Q2 2018.

Edge Advisors held 1,305 shares of iShares Biotechnology ETF worth $143K as of Q2 2018.
Edge Advisors sold 44 iShares Biotechnology ETF shares in Q2 2018, an estimated $4.71K.
iShares Biotechnology ETF made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #357 holding.
Edge Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 7 quarters since.
Edge Advisors's iShares Biotechnology ETF position peaked at $145K in Q3 2017.
609 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.